Browsing Tag
HealthCare Royalty
3 posts
BridgeBio raises $1bn in preferred equity to fund rare disease product launches
BridgeBio’s $1 billion preferred equity raise strengthens BBIO’s balance sheet as Attruby grows and three rare disease launches approach.
REGENXBIO monetizes gene therapy royalties in $250m deal with HCRx
REGENXBIO advances strategic funding deal with Healthcare Royalty to monetize Zolgensma and pipeline royalties while preserving upside from NAV platform assets and AbbVie/Nippon Shinyaku partnerships.
Liquidia Corporation shares soar 13% following dual financing announcement
Liquidia Corporation experienced a dramatic surge in its stock price, climbing 13% to $10.02, following the announcement of…